Ingevity Corp Stock
Price
Target price
?
?
0.000%
-
0.000%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Ingevity Corp Stock
The Ingevity Corp price is unchanged compared to yesterday.
Pros and Cons of Ingevity Corp in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ingevity Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ingevity Corp | 0.000% | 4.688% | 6.349% | 50.901% | 34.107% | 38.430% | - |
| PTT Global Chemical -fgn- | 3.740% | 4.469% | 9.357% | 54.545% | 74.766% | -7.426% | -37.667% |
| Barito Pacific Tbk PT | -3.070% | 3.165% | 17.266% | -33.197% | -47.756% | 139.706% | 69.792% |
| Braskem Pfd ADR | -2.060% | -4.412% | -13.717% | -27.239% | -19.421% | -76.647% | -89.344% |
Comments
Ingevity (NGVT) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for NGVT provided by MarketBeat
Ingevity (NGVT) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for NGVT provided by MarketBeat
Ingevity (NGVT) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for NGVT provided by MarketBeat
News
Ingevity Q2 Earnings Call Highlights
Key Points
- Interested in Ingevity Corporation? Here are five stocks we like better.
- Strong second-quarter performance: Excluding the divested Road Markings business, sales rose 5%, while
Ingevity Q1 Earnings Call Highlights
Ingevity (NYSE:NGVT) reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as management highlighted progress on portfolio simplification, strong margins in its Performance
Investor Builds $6 Million Position in Surging Chemicals Name Beating the S&P 500 by Nearly 40 Points
On February 17, 2026, EVR Research disclosed a new position in Ingevity (NYSE:NGVT), acquiring 100,000 shares worth $5.92 million.
In a U.S. Securities and Exchange Commission (SEC) filing dated
